Alpha-pharma Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Alpha-pharma Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $263.0K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Alpha-pharma Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $263.0K Trade | TransData Nexus

Alpha-pharma Healthcare Private Limited

Indian Pharmaceutical Exporter · Diabetes & Endocrine Specialist · $263.0K Total Trade · DGFT Verified

Alpha-pharma Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $263.0K across 3 products in 3 therapeutic categories. Based on 215 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Empagliflozin ($157.3K), Semaglutide ($89.5K), Tofacitinib ($16.2K).

Alpha-pharma Healthcare Private Limited — Export Portfolio & Destination Treemap

Alpha-pharma Healthcare Private Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Alpha-pharma Healthcare Private Limited? — Company Overview & Market Position

Alpha-Pharma Healthcare Private Limited, established on January 15, 2014, is a private unlisted company headquartered in Ambarnath, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U74999MH2014FTC252081. As of March 6, 2026, Alpha-Pharma has an authorized capital of ₹20.00 crore and a paid-up capital of ₹18.98 crore. The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its product portfolio spans three therapeutic categories: Diabetes & Endocrine, Advanced Diabetes Medications, and Advanced Oncology.

In the fiscal year 2022, Alpha-Pharma reported a 32.16% increase in revenue, a 232.23% rise in profit, and a 43.26% growth in net worth, indicating robust financial performance. The company's mission is to improve the quality of life by expanding global access to trusted, affordable therapies, combining scientific rigor, compliant manufacturing, and responsible supply to reduce the overall cost of care. (alpha-pharma.co)

What Does Alpha-pharma Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Empagliflozin$157.3K

Product Portfolio — Top 3 by Export Value

Alpha-pharma Healthcare Private Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Empagliflozin	Diabetes & Endocrine	$157.3K	106	2.3%	10
2	Semaglutide	Advanced Diabetes Medications	$89.5K	41	1.8%	12
3	Tofacitinib	Advanced Oncology	$16.2K	68	0.4%	12

Alpha-pharma Healthcare Private Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $263.0K. The top category is Diabetes & Endocrine (59.8% of portfolio), followed by Advanced Diabetes Medications (34.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Alpha-pharma Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Alpha-Pharma operates a manufacturing facility located at Unit 11, Mukta Heights, B-Wing, Near Shashwat Park, Badlapur West, Ambarnath, Maharashtra, 421503, India. The plant is compliant with current Good Manufacturing Practices (cGMP), ensuring the production of high-quality pharmaceutical formulations. The facility specializes in the production of finished dosage forms, including tablets, capsules, syrups, and injections, catering to various therapeutic areas such as Diabetes & Endocrine, Advanced Diabetes Medications, and Advanced Oncology.

3Key Leadership

Alpha-Pharma's leadership comprises two directors:

Jacob Sporon Fiedler: Appointed on January 15, 2014, he has been associated with the company since its inception.

Hrangdanglien: Joined as a director on May 27, 2019, bringing valuable experience to the leadership team.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Alpha-pharma Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Alpha-Pharma's export activities are primarily focused on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, across three therapeutic categories:

Diabetes & Endocrine: 59.8% of total exports, with top products like Empagliflozin and Semaglutide.

Advanced Diabetes Medications: 34.0% of total exports, featuring products such as Semaglutide.

Advanced Oncology: 6.2% of total exports, including products like Tofacitinib.

The company's export value stands at $263,000 USD, with 215 shipments, indicating a focused product portfolio. Notably, Empagliflozin holds a 2.3% market share, ranking 10th, while Semaglutide has a 1.8% market share, ranking 12th. Tofacitinib, with a 0.4% market share, also ranks 12th. Alpha-Pharma's strategic focus on these therapeutic areas aligns with global health priorities, particularly in managing diabetes and oncology conditions.

2Emerging Markets

Alpha-pharma Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Alpha-Pharma's export activities are primarily focused on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, across three therapeutic categories:

Diabetes & Endocrine: 59.8% of total exports, with top products like Empagliflozin and Semaglutide.

Advanced Diabetes Medications: 34.0% of total exports, featuring products such as Semaglutide.

Advanced Oncology: 6.2% of total exports, including products like Tofacitinib.

2WHO & EU GMP

Alpha-pharma Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Alpha-Pharma operates in the competitive pharmaceutical export market, focusing on finished formulations in therapeutic areas such as Diabetes & Endocrine, Advanced Diabetes Medications, and Advanced Oncology. While specific competitors are not identified in the available data, the company's emphasis on quality manufacturing practices and cost-efficient therapies positions it to compete effectively in these segments. To enhance its market position, Alpha-Pharma could consider expanding its product portfolio and exploring new therapeutic areas, thereby broadening its competitive edge.

2Key Differentiators

Alpha-Pharma's key differentiators include its commitment to improving the quality of life by expanding global access to trusted, affordable therapies. The company emphasizes compliant manufacturing and responsible supply to reduce the overall cost of care. Additionally, Alpha-Pharma has introduced micro tablets, a series of micronized tablets designed to achieve superior particle size distribution, enhancing dissolution and bioavailability profiles. (alpha-pharma.co) These innovations reflect the company's dedication to quality and patient-centric solutions.

3Strategic Position

Frequently Asked Questions — Alpha-pharma Healthcare Private Limited

How many pharmaceutical products does Alpha-pharma Healthcare Private Limited export from India?

Alpha-pharma Healthcare Private Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Empagliflozin ($157.3K), Semaglutide ($89.5K), Tofacitinib ($16.2K). Total export value is $263.0K.

What is Alpha-pharma Healthcare Private Limited's total pharmaceutical export value?

Alpha-pharma Healthcare Private Limited's total pharmaceutical export value is $263.0K, based on 215 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Alpha-pharma Healthcare Private Limited cover?

Alpha-pharma Healthcare Private Limited exports across 3 therapeutic categories. The largest are Diabetes & Endocrine (59.8%, 1 products), Advanced Diabetes Medications (34.0%, 1 products), Advanced Oncology (6.2%, 1 products).

Get Full Alpha-pharma Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.